Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today launched distribution of Monkeypox and Varicella-Zoster Viruses Real Time PCR Detection Kits in response to the world’s major Monkeypox outbreak. These specialized diagnostic kits are available now in Europe and can be found by contacting the company’s sales representatives.
The test is intended to aid in the rapid diagnosis of Monkeypox and varicella-zoster viruses in human serum and lesion exudate specimens, providing a preliminary test result. Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status.
https://finance.yahoo.com/news/virax-biolabs-introduces-monkeypox-varicella-120000114.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.